MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162 AM2)
by on Thursday, March 1st, 2012 | No Comments
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe (+) atorvastatin; Drug: Comparator: ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin; Drug: Comparator: rosuvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: rosuvastatin
Sponsor: Merck
Recruiting – verified February 2012
Excerpt from: MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162 AM2)